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New research suggests that the significance of TB for the prevalence 
of cystic fibrosis mutations in European populations may have 
been overlooked as fears grow over the threat from aggressive new 
drug- resistant strains. Nigel Williams reports.
Footprint fears for new TB threatOf all the diseases and illnesses 
that afflict human populations, 
tuberculosis is one that has had 
significant historical impact, 
but presently lies outside most 
people’s concern. But new work 
suggests just how much impact 
TB may have had on the European 
population, appearing to leave 
a footprint in the genome that 
accounts for a high level of cystic 
fibrosis mutations.
Cystic fibrosis is the most 
common lethal single-gene 
mutation in people of European descent, with a carrier frequency 
upwards of 2 per cent. Based 
upon molecular research, 
resistances in the heterozygote 
to cholera and typhoid fever 
have been proposed to explain 
the persistence of the mutation. 
Using a population genetic model 
parameterised with historical 
demographic and epidemiological 
data, Eric Poolman and Alison 
Galvani at Yale University show 
in a paper in the Journal of the 
Royal Society Interface (published 
online), that neither cholera nor typhoid fever provided enough 
historical selective pressure to 
produce the modern incidence of 
cystic fibrosis.
However, the authors show 
that the European tuberculosis 
pandemic beginning in the 
seventeenth century would have 
provided sufficient historical, 
geographically appropriate 
selective pressure under 
conservative assumptions.
Tuberculosis has been 
underappreciated as a possible 
selective agent in producing cystic 
fibrosis but has clinical, molecular 
and now historical, geographical 
and epidemiological support. 
And last month, world health 
officials put out an unprecedented New threat: Extreme drug-resistant strains of tuberculosis are an increasing problem for health authorities around the world. (Picture: 
Science Photo Library.)
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Blooming alarm
Residents of the remote 
north-east Indian state 
of Mizoram are currently 
facing an almost only 
once-in-a-lifetime show: 
the spectacular flowering 
of native bamboo, which 
occurs only once every 
47–48 years. But rather than 
relishing the sight, the locals 
are full of dread for folklore 
has it that the flowers are 
a harbinger of famine. And 
this is not mere superstition, 
but soundly based in  
fact.
Bamboo species are 
remarkable for their 
varying periodicities 
of flowering – from 
annually to once only 
every 120 years – and the 
synchronisation of flowering 
within one species in one 
area. Some species show 
quite distinct periodicities 
at different geographical 
locations. But the outcome 
of these mass flowerings is 
the same: the production of 
vast amounts of protein-rich 
seeds. And it is the gorging 
on these seeds by the local 
rat populations which then 
explode in size, that is the 
cause of worry for Mizoram’s 
people.
When the seed supply 
dries up the huge rat 
population turns to human 
crops and stores in search of 
food.
Although the main 
blossoming of the local 
bamboo is not expected 
until next year, in some 
regions there are already 
reports of rats invading 
paddy crops and granaries. 
“Countless numbers of 
rats raided paddy crops 
in two villages during 
night-time, while there 
were reports of a moderate 
rat invasion coming from 
other areas of the state,” 
said James Laisiamiliana, 
a Mizoram government 
agricultural scientist, last 
month.warning that deadly new 
strains of tuberculosis, virtually 
untreatable using the drugs 
currently available, appear 
to be spreading across the 
globe, raising the spectre of a 
resurgence in a disease which 
for many generations has laid 
in the background, seemingly 
beaten, but which may now make 
a major comeback as a lethal new 
pathogen.
The new strains are known 
as extreme drug-resistant TB 
or XDR- TB. They have been 
identified and have killed people 
in several countries, including the 
US and Eastern Europe, and they 
have recently been found in Africa, 
where they could swiftly put an 
end to all hope of containing the 
Aids pandemic through treatment.
Paul Nunn, head of the WHO’s 
TB resistance team, said the 
situation was very serious. There 
are nine million cases of TB in the 
world and the WHO estimates 
that two per cent of them — or 
180,000 — could be XDR-TB. “This 
is raising the spectre of something 
that we have worried might happen 
for a decade — the possibility of 
virtually untreatable TB,” he said.
Even in the US, which has the 
best medicines available, a third 
of those diagnosed with XDR-TB 
have died. In March, the Centers 
for Disease Control registered 
64 cases in the US; 21 of those 
ended in death.
Significant numbers of cases 
have been confirmed in Latvia and 
Russia, but in many parts of the 
world XDR-TB could be present 
but unrecognised. One of the 
reasons the WHO is concerned is 
that tuberculosis spreads easily 
in confined spaces, such as 
aircraft. Multi-drug resistant TB 
strains — those that are resistant 
to the two basic, first-line drugs 
used to treat the disease — have 
spread everywhere, including to 
the UK. Multi-drug resistant TB is 
increasingly common and difficult 
and expensive to treat. The patient 
must be given four out of the six 
existing second-line drugs. But 
the XDR-TB strains now appearing 
seem resistant to at least three out 
of those six second-line drugs and 
there are no third-line drugs.
The spectre of a new outbreak 
of untreatable TB has been raised because of the identification of a 
cluster of cases in KwaZulu-Natal, 
South Africa. Researchers studied 
544 TB patients and found 221 
had strains against which the 
two common drugs had no 
effect. They further found that 
53 of the patients had XDR-TB, 
and 52 of them died within an 
average of 25 days. All these 
patients were HIV-positive, so the 
occurrence of XDR-TB may have 
major implications for anti-viral 
treatments.
While the situation in South 
Africa has heightened global 
concern about the new TB strains, 
any leads that may generate 
new approaches to therapy are 
urgently sought.
Poolman and Galvani hope 
their work may lead to one 
new avenue. Resistance to 
tuberculosis in cystic fibrosis 
patients was recently considered 
to arise from diminished activity of 
the enzyme arylsulphatase B. The 
tuberculosis bacilli lack intrinsic 
arylsulphatase activity, but they 
have an arylsulphotransferase 
that may require sulphate from 
the host to construct their 
cell walls. Cell wall sulphate 
content has been correlated with 
virulence, so dysfunction of host 
arylsulphatase activity in cystic 
fibrosis may help protect against 
TB by depriving the bacteria 
of a necessary nutrient, write 
Poolman and Galvani. “Our result 
supports the importance of novel 
investigations into the role of 
arylsulphatase B deficiency in 
cystic fibrosis and tuberculosis,” 
they say.
With South African researchers 
working desperately to contain the 
outbreak there, any new leads are 
welcome.
Their work highlights the impact 
of tuberculosis in the past in 
Europe. “Tuberculosis combines 
ancient endemicity with a recent 
epidemic of European origin 
and severe mortality, particularly 
among young adults at the peak 
of their reproductive potential. 
Consequently, tuberculosis 
would provide sufficient selective 
pressure in the correct parts of 
the world,” their study suggests. 
The newly drug-resistant disease’s 
more global current occurrence is 
cause for future concern.
